BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,004,963 | -15.8% | 768,547 | +1.6% | 0.10% | -27.3% |
| Q2 2023 | $34,460,991 | +19.8% | 756,387 | +6.6% | 0.14% | +1.5% |
| Q1 2023 | $28,774,683 | +314.4% | 709,435 | +420.7% | 0.14% | +197.8% |
| Q4 2022 | $6,944,407 | -99.2% | 136,245 | +859.5% | 0.05% | +475.0% |
| Q2 2022 | $912,066,000 | -10.1% | 14,200 | +18.1% | 0.01% | -27.3% |
| Q1 2021 | $1,014,441,000 | -32.7% | 12,028 | -36.0% | 0.01% | -21.4% |
| Q4 2020 | $1,506,907,000 | +79.6% | 18,780 | +80.0% | 0.01% | +40.0% |
| Q3 2020 | $839,182,000 | +52381.7% | 10,435 | -47.0% | 0.01% | -60.0% |
| Q1 2020 | $1,599,000 | +80.7% | 19,700 | +86.1% | 0.02% | +257.1% |
| Q4 2019 | $885,000 | -40.8% | 10,587 | -38.1% | 0.01% | -46.2% |
| Q3 2019 | $1,495,000 | -51.6% | 17,100 | -54.6% | 0.01% | -53.6% |
| Q2 2019 | $3,088,000 | +1254.4% | 37,700 | +1246.4% | 0.03% | +1300.0% |
| Q1 2019 | $228,000 | -96.9% | 2,800 | -97.5% | 0.00% | -96.9% |
| Q4 2018 | $7,255,000 | +221.0% | 110,216 | +260.1% | 0.06% | +433.3% |
| Q2 2018 | $2,260,000 | +240.9% | 30,609 | +200.1% | 0.01% | +200.0% |
| Q1 2018 | $663,000 | -94.5% | 10,200 | -94.5% | 0.00% | -93.9% |
| Q4 2017 | $12,046,000 | +805.0% | 186,358 | +779.0% | 0.07% | +633.3% |
| Q3 2017 | $1,331,000 | -91.4% | 21,200 | -91.7% | 0.01% | -92.8% |
| Q2 2017 | $15,428,000 | -43.1% | 254,852 | -51.3% | 0.12% | -44.7% |
| Q1 2017 | $27,137,000 | +229.2% | 523,282 | +181.5% | 0.23% | +218.3% |
| Q4 2016 | $8,243,000 | +160.0% | 185,913 | +179.1% | 0.07% | +144.8% |
| Q3 2016 | $3,170,000 | -48.8% | 66,600 | -51.3% | 0.03% | -50.0% |
| Q2 2016 | $6,186,000 | +78.2% | 136,800 | +61.9% | 0.06% | +70.6% |
| Q1 2016 | $3,472,000 | -37.6% | 84,507 | -42.1% | 0.03% | -40.4% |
| Q4 2015 | $5,563,000 | +268.9% | 145,840 | +217.7% | 0.06% | +235.3% |
| Q3 2015 | $1,508,000 | -98.3% | 45,900 | -96.5% | 0.02% | -98.5% |
| Q2 2015 | $90,536,000 | +1787.3% | 1,294,658 | +1878.3% | 1.15% | +1915.8% |
| Q4 2014 | $4,797,000 | -38.5% | 65,443 | -39.7% | 0.06% | -35.2% |
| Q3 2014 | $7,794,000 | +13.1% | 108,600 | +14.0% | 0.09% | +20.5% |
| Q2 2014 | $6,891,000 | +307.0% | 95,300 | +314.3% | 0.07% | +247.6% |
| Q1 2014 | $1,693,000 | -84.1% | 23,000 | -85.0% | 0.02% | -84.0% |
| Q4 2013 | $10,641,000 | +7.6% | 153,000 | +1.6% | 0.13% | -4.4% |
| Q3 2013 | $9,888,000 | -22.8% | 150,525 | -18.6% | 0.14% | -30.1% |
| Q2 2013 | $12,804,000 | – | 184,849 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |